ERBB2 c.416A>T ;(p.E139V)

Variant ID: 17-37864764-A-T

NM_004448.2(ERBB2):c.416A>T;(p.E139V)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


SPP1 overexpression is associated with poor outcomes in ALK fusion lung cancer patients without receiving targeted therapy.

Scientific Reports
Ji, Xiaolin X; Liu, Yan Y; Mei, Fang F; Li, Xinyang X; Zhang, Mengxue M; Yao, Buwen B; Wu, Rui R; You, Jiangfeng J; Pei, Fei F
Publication Date: 2021-07-07

Variant appearance in text: HER2: E139V
PubMed Link: 34234236
Variant Present in the following documents:
  • Main text
View BVdb publication page